Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes

Canadian Journal of Cardiology

Volumn 19, Issue 3, 2003, Pages 257-263

  Khadour, Fadi H ^a   Fu, Yuling ^a   Chang, Wei Ching ^a   Ma, Xin ^a   Mark, Dan ^b   Granger, Christopher B ^b   Topol, Eric J ^c   Califf, Robert M ^b   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Catheterization; Coronary; Mortality; Myocardial infarction; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN; NITRATE; RECOMBINANT HIRUDIN; STREPTOKINASE;

ACUTE DISEASE; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH CARE FACILITY; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RACE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVASCULARIZATION; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; CANADA; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; HEALTH CARE DELIVERY; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RADIOGRAPHY; STANDARD; SYNDROME; UNITED STATES; UTILIZATION REVIEW;

ACUTE DISEASE; AGED; CANADA; CARDIAC CARE FACILITIES; CARDIOLOGY SERVICE, HOSPITAL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEART CATHETERIZATION; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SYNDROME; TREATMENT OUTCOME; UNITED STATES;

EID: 0037445088     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction, 1999 update: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). American College of Cardiology and American Heart Association versions current at April 1999.
2. Blustein J. High-technology cardiac procedures. The impact of service availability on service use in New York State. JAMA 1993;270:344-9.
3. Every NR, Larson EB, Litwin PE, et al, for the MITI investigators. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993;329:546-51.
4. Every NR, Parsons LS, Fihn SD, et al, for the MITI investigators. Long term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation 1997;96:1770-5.
5. Feit F, Mueller HS, Braunwald E, et al. Thrombolysis in myocardial infarction (TIMI) phase II trial: Outcome comparison of a 'conservative strategy' in community versus tertiary hospitals. J Am Coll Cardiol 1990;16:1529-34.
6. Krumholz HM, Chen J, Murillo JE, et al. Admission to hospitals with on-site cardiac catheterization facilities. Impact on long term costs and outcomes. Circulation 1998;98:2010-6.
7. Marrugat J, Sanz G, Masia R, et al, for the RESCATE investigators. Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. J Am Coll Cardiol 1997;30:1187-92.
8. Rogers WJ, Canto JG, Barron HV, et al, for the investigators in the National Registry of Myocardial Infarction 2. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol 2000;35:371-9.
9. Yusuf S, Flatcher M, Pogue J, et al, for the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998;352:507-14.
10. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndrome. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N Engl J Med 1996;335:775-82.
11. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO) IIb, angioplasty substudy investigators. N Engl J Med 1997;336:1621-8.
12. Alter DA, Naylor CD, Austin PC, Tu JV. Long term MI outcomes at hospitals with or without on-site revascularization. JAMA 2001;285:2101-8.
13. Allison JJ, Kiefe CI, Weissman NW, et al. Relationship of hospital teaching status with quality of care and mortality for medicare patients with acute MI. JAMA 2000;284:1256-62.
14. Welty FK. Optimal management of non-ST elevation myocardial infarction remains unclear. J Am Coll Cardiol 2000;35:903-6.
15. Cannon CP, Weintraub WS, Demopoulos LA, et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy): Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1939-87.